This past weekend was the calm before the storm for a wide swath of the Prairies, as one soaker of a system pushes into the region to start the new work week
Shah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest shareholder, reiterated that the company was "undervalued and continues to suffer from poor profitability". The top shareholder had expressed concerns about mismanagement at the Maryland-based biotech and nominated two of its own candidates for the board last month. It had also urged Novavax to adopt a marketing strategy to target consumers who are hesitant to receive mRNA vaccines.